Cinclus Pharma Holding AB (publ) (STO:CINPHA)
Sweden · Delayed Price · Currency is SEK 16.70
-0.16 (-0.95%)
At close: Feb 9, 2026
Cinclus Pharma Holding AB Market Cap
Cinclus Pharma Holding AB has a market cap or net worth of 777.18 million as of February 10, 2026. Its market cap has decreased by -9.92% in one year.
Market Cap
777.18M
Enterprise Value
245.61M
Revenue
48.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.70
Market Cap Chart
Since June 20, 2024, Cinclus Pharma Holding AB's market cap has decreased from 1.52B to 777.18M, a decrease of -48.78%. That is a compound annual growth rate of -33.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 777.18M | -13.29% |
| Dec 30, 2025 | 896.32M | -9.92% |
| Dec 30, 2024 | 994.98M | -34.43% |
| Jun 20, 2024 | 1.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 11.05B |
| Cereno Scientific AB | 2.10B |
| EQL Pharma AB | 1.82B |
| Orexo AB | 976.50M |
| Dicot Pharma AB | 661.07M |
| Nanexa AB | 592.66M |
| Enzymatica AB | 449.06M |
| Moberg Pharma AB | 430.29M |